Catherine Van Raamsdonk

Associate Professor

Research Classification

Cancer Genetics
Developmental Genetics
Molecular Genetics

Research Interests

Human Cancer Genetics
Developmental Genetics
Mouse Genetics and Transgenesis
Melanoma
Oncogenesis
Melanocytes
Pigmentation

Relevant Degree Programs

 

Research Methodology

Mouse genetics
Human genetics
Cancer genetics
Genomics
bioinformatics

Recruitment

Complete these steps before you reach out to a faculty member!

Check requirements
  • Familiarize yourself with program requirements. You want to learn as much as possible from the information available to you before you reach out to a faculty member. Be sure to visit the graduate degree program listing and program-specific websites.
  • Check whether the program requires you to seek commitment from a supervisor prior to submitting an application. For some programs this is an essential step while others match successful applicants with faculty members within the first year of study. This is either indicated in the program profile under "Requirements" or on the program website.
Focus your search
  • Identify specific faculty members who are conducting research in your specific area of interest.
  • Establish that your research interests align with the faculty member’s research interests.
    • Read up on the faculty members in the program and the research being conducted in the department.
    • Familiarize yourself with their work, read their recent publications and past theses/dissertations that they supervised. Be certain that their research is indeed what you are hoping to study.
Make a good impression
  • Compose an error-free and grammatically correct email addressed to your specifically targeted faculty member, and remember to use their correct titles.
    • Do not send non-specific, mass emails to everyone in the department hoping for a match.
    • Address the faculty members by name. Your contact should be genuine rather than generic.
  • Include a brief outline of your academic background, why you are interested in working with the faculty member, and what experience you could bring to the department. The supervision enquiry form guides you with targeted questions. Ensure to craft compelling answers to these questions.
  • Highlight your achievements and why you are a top student. Faculty members receive dozens of requests from prospective students and you may have less than 30 seconds to pique someone’s interest.
  • Demonstrate that you are familiar with their research:
    • Convey the specific ways you are a good fit for the program.
    • Convey the specific ways the program/lab/faculty member is a good fit for the research you are interested in/already conducting.
  • Be enthusiastic, but don’t overdo it.
Attend an information session

G+PS regularly provides virtual sessions that focus on admission requirements and procedures and tips how to improve your application.

 

Master's students
Doctoral students
2020
2021

Cancer cell metastasis. Neural crest cell development. Molecular analysis of melanocytes and melanoma cells from mouse models: transcriptomics, bioinformatics, proteomics. Primary cell culture, FACS, Immunohistochemistry/Immunofluorescence. Therapeutics and signaling pathways in melanoma.

I support experiential learning experiences, such as internships and work placements, for my graduate students and Postdocs.
I am interested in and conduct interdisciplinary research.
I am interested in supervising students to conduct interdisciplinary research.

Graduate Student Supervision

Doctoral Student Supervision (Jan 2008 - May 2019)
The role of Adamts9 in melanoblast migration and modification of the skin proteome (2015)

The glabrous skin, which includes, the tail, the footpads, the nose and the ears, of the mouse retain melanocytes in the dermis, the hair follicles of the epidermis and the interfollicular regions of the epidermis. Given that melanocytes in humans are exclusively found in the epidermis and hair follicles, the epidermis of the glabrous skin of the mouse can be a functional model in the study of melanocytes. A dominant N-ethyl-N-nitrosourea (ENU) mutagenesis screen of C3HeB/FeJ mice at the National Research Center for Environment and Health (GSF) in Germany recovered two mutants, Und3 and Und4. These mice are characterized by a reduction in pigmentation that is localized to the middle regions of the tail, with the base and tip retaining pigmentation. Mapping and sequencing revealed single base pair changes in Adamts9. The mutations in Adamts9 create null alleles and Adamts9, expressed in the epidermis, is required for melanoblast migration in the tail at 18.5 dpc. A conditional knockout of Adamts9 suggests that the hypopigmentation is due to the loss of Adamts9 in melanocytes, but not keratinocytes. Terminal amine isotopic labeling of substrates (TAILS) was used to identify changes in potential cleavage processes between Adamts9Und4/+ and wildtype mice. Several candidates, associated with the stratum basale, were found to be significantly different between the wildtype and the mutant proteomes. These candidates are involved in the regulation of cytoplasmic cell structure (Filamin-A, Filamin-B, beta-tubulin 4A and alpha-tubulin 1C), maintaining the structural organization of cells within the extracellular matrix (Plectin, Desmoplakin, Perisotin and Vimentin) and communication between cells (Type XII collagen, Type VII collagen, Fibrillin-1, Fibronectin, Tenascin and Biglycan). These findings suggest that Adamts9 is essential for the appropriate migration of melanoblasts in the developing embryo and immediately after birth. Additionally, this protease is likely involved in mouse pigmentation by maintaining an environment in the stratum basale that supports the migration of melanoblasts in the epidermis through the activation of proliferation pathways during development. Supplementary video material is available at: http://hdl.handle.net/2429/52938

View record

Role of Nf1 signaling in regulating pigmentation in the mouse (2012)

Neurofibromatosis type 1 is caused by mutations in neurofibromin (NF1). Neurofibromas, which are Schwann cell based tumors, and skin hyper-pigmentation are characteristic of NF1 loss. Melanocytes differentiate from Schwann cell precursors (SCPs) during development, suggesting that there may be a mechanistic link between these NF1-related manifestations. In this thesis, we use Cre-LoxP technology to test the cell types that require Nf1 for normal pigmentation. We discovered that an Nf1 targeted knockout (Nf1tm1Par) and an ENU-generated N1453K substitution in Nf1 (Nf1Dsk9) are associated with darker skin in mice. Nf1Dsk9/Nf1Dsk9 embryos exhibit increased numbers of melanoblasts at E10.5, and Nf1 -/- knock out in already committed melanoblasts causes dermal and epidermal hyper-pigmentation. In contrast, Nf1Dsk9/+ embryos exhibit an increase in the number of melanoblasts beginning at E12.5, and Nf1 +/- knockout in already committed melanoblasts has no effect on skin pigmentation. Nf1 haploinsufficiency in SCPs causes hyper-pigmentation of the dermis (but not the epidermis) in tamoxifen-inducible Plp1-CreER/+; Nf1tm1Par/+ mice when tamoxifen is administered at E11.5. Consistent with a lack of epidermal darkening in these mice, we found that cells expressing Plp1-CreER at E11.5 do not persist in the adult epidermis.We found that Nf1 regulates skin pigmentation by an endothelin-dependent, as well as an independent mechanism. Nf1Dsk9/+;Ednrbs-l/Ednrbs-l mice lack tail skin pigmentation, like +/+;Ednrbs-l/Ednrbs-l mice. However, Nf1Dsk9/+;Ednrbs-l/Ednrbs-l mice exhibit an increased percentage of pigmented coat compared to +/+;Ednrbs-l/Ednrbs-l mice. Our data suggests that there are at least two mechanisms by which Nf1 regulates pigmentation in mice. Two copies of Nf1 are required to determine the appropriate number of melanoblasts that differentiate from bipotent melanoctye-SCPs. Subsequently, at least one copy of Nf1 is required to restrain the number of melanoblasts in the epidermis and dermis after they have committed to the melanocyte fate. These findings suggest that neurofibromin plays an important role in the specification of melanocytes within the glial lineage and may help design therapeutic options for treating NF1-related hyper-pigmentation in the future.

View record

Master's Student Supervision (2010 - 2018)
Ocular melanocytes respond to oncogenic GNAQQ209L differently compared to epidermal and dermal melanocytes in mice (2015)

Somatic mutations in the homologous human oncogenes GNAQ, and GNA11, are frequently found in ocular melanomas of the uvea, blue nevi of the dermis, and melanocytic neoplasias of the central nervous system (CNS), but rarely in cutaneous melanoma located in the epidermis (0.3%). The most common mutation found in GNAQ/11 is the amino acid substitution Q209L in the Ras-like GTPase domain. It causes complete or partial loss of intrinsic GTPase activity thereby locking the protein in a constitutively active form. To compare the downstream signal transduction effects of GNAQQ²⁰⁹L on melanocytes in different locations such as the dermis, the epidermis, ears, eyes and CNS, the mutant gene was conditionally knocked-in to the ubiquitous Rosa26 locus in mice to normalize gene expression among melanocytes. When expression of GNAQQ²⁰⁹L was induced in melanoblasts (immature melanocytes) during embryogenesis, the mice exhibit hyperpigmentation in the dermis of the tail, footpad, trunk, and ears beginning at a young age, with non-cutaneous melanocyte overgrowth in the inner ear and CNS, and metastatic uveal melanoma in older animals. In older adult mice, a progressive loss of melanocytes occurred in the inter-follicular epidermis, which could explain the lack of GNAQ mutations in human cutaneous melanomas located in the epidermis. When expression of GNAQQ²⁰⁹L was induced in mature melanocytes in adult, some of the above phenotypes such as hyperpigmentation in the dermal skin and uveal track thickening in the eyes were observed. When expression of GNAQQ²⁰⁹L was induced in bipotential Schwann cell precursors, there was a decrease in the number of melanoblasts, suggesting that GNAQQ²⁰⁹L blocks the production of melanoblasts from Schwann cell precursors.Altogether, I developed the first mouse uveal melanoma model driven by oncogenic mutant GNAQQ²⁰⁹L gene. These mice display all three types of lesions driven by constitutively active GNAQ in human: blue nevi, uveal melanoma, and invasive melanocytic neoplasias of the CNS. I show that the downstream effects of GNAQQ²⁰⁹L on melanocytes are strongly dependent upon cellular context, as seen in the differences presented in the epidermis, dermis, uveal and CNS melanocytes.

View record

Publications

 
 

If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.